Class-Action suit could cost French firm over $300M

Sanofi-aventis U.S., the American branch of a French pharmaceutical group, has been hit with a class-action sexual discrimination and harassment lawsuit. The four plaintiffs claim they were paid less and not promoted because of their gender. The women also say their bosses made unwelcome sexual comments and gestures, and management did not respond when they complained ...